{"id":32574,"date":"2024-12-27T00:00:00","date_gmt":"2024-12-27T00:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4586067_AE86067_0"},"modified":"2024-12-27T00:00:00","modified_gmt":"2024-12-27T00:00:00","slug":"vista-eye-specialist-revolutionizes-dry-eye-treatment-with-groundbreaking-research-and-advanced-technology","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=32574","title":{"rendered":"VISTA Eye Specialist Revolutionizes Dry Eye Treatment with Groundbreaking Research and Advanced Technology"},"content":{"rendered":"

PETALING JAYA, Malaysia<\/span><\/span>, Dec. 27, 2024<\/span><\/span> \/PRNewswire\/ — VISTA Eye Specialist (VISTA), Malaysia’s<\/span> leading eye care provider, proudly announces a major milestone in the treatment of dry eye disease. A groundbreaking study led by Dr. Aloysius Joseph Low<\/span>, Medical Director and Ms. Azarina Abdullah<\/span>, Optometrist <\/b>has been published in the esteemed Journal of Health Science and Medical Research<\/i>. This achievement firmly establishes VISTA as a trailblazer in ophthalmology innovation across Southeast Asia<\/span>.<\/p>\n

\n

\"An <\/a>
An Optometrist from VISTA Eye Specialist is performing the IRPL therapy for dry eye patient.<\/span><\/p>\n<\/p><\/div>\n

Dry eye disease is on the rise worldwide, driven by modern lifestyle factors such as prolonged screen time, air-conditioned environments, and aging populations among others. This chronic condition affects millions, causing significant discomfort and diminishing quality of life for sufferers.<\/p>\n

Innovative E>Eye IRPL Therapy<\/b><\/p>\n

In response to the growing burden of dry eye disease, VISTA is spearheading a revolutionary approach with E>Eye Intense Regulated Pulsed Light (IRPL) therapy<\/b>, a cutting-edge treatment designed to address evaporative dry eye disease caused by meibomian gland dysfunction (MGD).<\/p>\n

The study, titled “The Effectiveness of E>Eye Intense Regulated Pulsed Light Therapy in Treating Evaporative Dry Eye Disease among Southeast Asian Patients,”<\/i> demonstrates the exceptional efficacy of this advanced therapy in restoring gland function, stabilizing tears, and improving overall eye comfort for patients in the region.<\/p>\n

Key Findings of the Research:<\/b><\/p>\n